H Brincker

4.6k total citations
93 papers, 3.4k citations indexed

About

H Brincker is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H Brincker has authored 93 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 28 papers in Pathology and Forensic Medicine and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H Brincker's work include Lymphoma Diagnosis and Treatment (21 papers), Sarcoidosis and Beryllium Toxicity Research (12 papers) and Acute Myeloid Leukemia Research (11 papers). H Brincker is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Sarcoidosis and Beryllium Toxicity Research (12 papers) and Acute Myeloid Leukemia Research (11 papers). H Brincker collaborates with scholars based in Denmark, United Kingdom and Finland. H Brincker's co-authors include E Wilbek, Francesco d’Amore, Niels T. Pedersen, K Thorling, Gunnar Sæter, M. G. Pedersen, Bjarne Christensen, Elo Andersen, Leif Spange Mortensen and Morten K. Jensen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

H Brincker

92 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Brincker Denmark 32 1.3k 1.0k 1.0k 852 509 93 3.4k
Richard L. Kempson United States 44 1.3k 1.0× 2.4k 2.3× 1.1k 1.0× 378 0.4× 627 1.2× 105 7.3k
Harold A. Oberman United States 39 655 0.5× 499 0.5× 1.3k 1.3× 347 0.4× 329 0.6× 130 3.8k
James B. Nachman United States 44 1.3k 1.0× 967 0.9× 1.0k 1.0× 267 0.3× 201 0.4× 125 6.9k
John W. Pickren United States 39 2.6k 2.1× 2.1k 2.0× 828 0.8× 143 0.2× 607 1.2× 95 5.2k
J. Robert Cassady United States 24 764 0.6× 705 0.7× 1.2k 1.1× 121 0.1× 196 0.4× 42 2.9k
James A. Strauchen United States 30 1.1k 0.9× 341 0.3× 1.1k 1.1× 283 0.3× 653 1.3× 97 2.5k
Peter F. Coccia United States 44 1.5k 1.2× 846 0.8× 1.1k 1.0× 149 0.2× 249 0.5× 108 5.7k
Georges Fillet Belgium 37 1.4k 1.1× 865 0.8× 2.1k 2.1× 243 0.3× 204 0.4× 151 5.3k
W M Hryniuk Canada 22 1.9k 1.5× 570 0.5× 570 0.6× 82 0.1× 275 0.5× 32 3.2k
Anna-Luise A. Katzenstein United States 38 738 0.6× 3.8k 3.6× 628 0.6× 906 1.1× 705 1.4× 62 5.2k

Countries citing papers authored by H Brincker

Since Specialization
Citations

This map shows the geographic impact of H Brincker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Brincker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Brincker more than expected).

Fields of papers citing papers by H Brincker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Brincker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Brincker. The network helps show where H Brincker may publish in the future.

Co-authorship network of co-authors of H Brincker

This figure shows the co-authorship network connecting the top 25 collaborators of H Brincker. A scholar is included among the top collaborators of H Brincker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Brincker. H Brincker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cartwright, R., H Brincker, Paule‐Marie Carli, et al.. (1999). The rise in incidence of lymphomas in Europe 1985–1992. European Journal of Cancer. 35(4). 627–633. 143 indexed citations
2.
Agerlin, Niels, F. Gjerris, H Brincker, et al.. (1999). Childhood medulloblastoma in Denmark 1960-1984. Child s Nervous System. 15(1). 29–37. 18 indexed citations
3.
Abildgaard, Niels, Jørgen Rungby, Henning Glerup, et al.. (1998). Long‐term oral pamidronate treatment inhibits osteoclastic bone resorption and bone turnover without affecting osteoblastic function in multiple myeloma. European Journal Of Haematology. 61(2). 128–134. 42 indexed citations
4.
Brincker, H, Niels Abildgaard, Peter Gimsing, et al.. (1998). Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double‐blind placebo‐controlled trial. British Journal of Haematology. 101(2). 280–286. 83 indexed citations
5.
d’Amore, Francesco, H Brincker, Kirsten Grønbæk, et al.. (1994). Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.. Journal of Clinical Oncology. 12(8). 1673–1684. 241 indexed citations
6.
Brincker, H. (1993). Direct intratumoral chemotherapy. Critical Reviews in Oncology/Hematology. 15(2). 91–98. 32 indexed citations
7.
Brincker, H & Bjarne Christensen. (1993). Acute mucocutaneous toxicity following high-dose hydroxyurea. Cancer Chemotherapy and Pharmacology. 32(6). 496–497. 18 indexed citations
8.
Cold, Søren, Niels Viggo Jensen, H Brincker, & Carsten Rose. (1993). The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970s. European Journal of Cancer. 29(8). 1146–1152. 36 indexed citations
9.
Brincker, H. (1992). Interpretation of Granulomatous Lesions in Malignancy. Acta Oncologica. 31(1). 85–89. 38 indexed citations
10.
d’Amore, Francesco, H Brincker, Bjarne Christensen, et al.. (1992). Original article: Non-Hodgkin's lymphoma in the elderly. Annals of Oncology. 3(5). 379–386. 85 indexed citations
11.
Mirza, Mansoor Raza, H Brincker, & Lena Specht. (1992). The integration of radiotherapy into the primary treatment of non-Hodgkin's lymphoma. Critical Reviews in Oncology/Hematology. 12(3). 217–229. 19 indexed citations
12.
Mirza, Mansoor Raza & H Brincker. (1991). Mime Combination Chemotherapy in Recurrent or Refractory Lymphoproliferative Malignancies: A Phase II Study. Acta Oncologica. 30(1). 17–21. 6 indexed citations
13.
14.
d’Amore, Francesco, Bjarne Christensen, H Brincker, et al.. (1991). Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. European Journal of Cancer and Clinical Oncology. 27(10). 1201–1208. 154 indexed citations
15.
Brincker, H. (1989). Coexistence of sarcoidosis and myeloproliferative disease: a case of sarcoidosis preceding polycythaemia vera with a literature review. Journal of Internal Medicine. 225(5). 355–357. 8 indexed citations
16.
Nygaard, Randi, Peter Johan Moe, H Brincker, et al.. (1989). Late relapses after treatment for acute lymphoblastic leukemia in childhood: A population‐based study from the nordic countries. Medical and Pediatric Oncology. 17(1). 45–47. 22 indexed citations
17.
Brincker, H. (1988). Distant Recurrence in Breast Cancer: Survival expectations and first choice of chemotherapy regimen. Acta Oncologica. 27(6). 729–732. 26 indexed citations
18.
Brincker, H. (1988). Scandinavia. Journal of Cancer Education. 3(2). 97–101. 11 indexed citations
19.
Brincker, H, et al.. (1987). Cyclic alternating polychemotherapy with or without upper and lower half-body irradiation in small cell anaplastic lung cancer. A randomized study. European Journal of Cancer and Clinical Oncology. 23(2). 205–211. 8 indexed citations
20.
Brincker, H, et al.. (1974). Development of pulmonary aspergillomas coinciding with induction of remission in acute myeloid leukaemia.. PubMed. 21(1). 37–40. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard L. Kempson Breakdown of academic impact, for papers by Harold A. Oberman Breakdown of academic impact, for papers by James B. Nachman Breakdown of academic impact, for papers by John W. Pickren Breakdown of academic impact, for papers by J. Robert Cassady Breakdown of academic impact, for papers by James A. Strauchen Breakdown of academic impact, for papers by Peter F. Coccia Breakdown of academic impact, for papers by Georges Fillet Breakdown of academic impact, for papers by W M Hryniuk Breakdown of academic impact, for papers by Anna-Luise A. Katzenstein
Rankless by CCL
2026